We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:
Medicine & public health

Search Results

Showing 21-40 of 1,823 results

  2. Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study

    The selective norepinephrine reuptake inhibitor atomoxetine is potentially among the first-line pharmacotherapy options for ADHD. Therapeutic drug...

    Katrin Ruppert, Christoph Geffert, ... Monica Biscaldi-Schäfer in Journal of Neural Transmission
    Article Open access 07 April 2022

  4. Efficacy and Safety of Methylphenidate and Atomoxetine in Medication-Naive Children with Attention-Deficit Hyperactivity Disorder in a Real-World Setting

    Background and Objective

    Methylphenidate (MPH) and atomoxetine (ATX) are the most common medications used to treat attention-deficit hyperactivity...

    Ying Zhang, Li Yin, ... Kaifeng Zhang in Drugs in R&D
    Article Open access 20 November 2023

  5. Atomoxetine/imipramine

    in Reactions Weekly
    Article 13 August 2022

  6. Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysis

    Background

    Recent guidelines emphasize the importance of functional outcomes in children with attention-deficit/hyperactivity disorder (ADHD). Here,...

    Armagan Aral, Merve Onat, Hilal Aydemir in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 19 August 2022

  8. Atomoxetine

    in Reactions Weekly
    Article 01 January 2022

  9. Atomoxetine

    in Reactions Weekly
    Article 23 October 2021

  10. Atomoxetine

    in Reactions Weekly
    Article 23 October 2021

  12. Effects of Atomoxetine Hydrochloride on Regulation of Lifespan in Drosophila Model

    Nootropics (smart drugs) are used by students to enhance cognitive performance which have been reported times in recent years. However, some of the...

    Jie Shen, J. Shan, ... M. Li in The journal of nutrition, health & aging
    Article 08 February 2022

  13. Atomoxetine

    in Reactions Weekly
    Article 17 April 2021

  14. The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment

    The stimulant methylphenidate (MPH) and the non-stimulant atomoxetine (ATX) are frequently used for the treatment of attention-deficit/hyperactivity...

    Susu Qu, Xiangyu Zhou, ... Li Zhang in Molecular Psychiatry
    Article Open access 13 November 2023

  15. Atomoxetine overdose

    in Reactions Weekly
    Article 20 March 2021

  16. Atomoxetine

    in Reactions Weekly
    Article 14 November 2020

  17. Medications for attention deficit hyperactivity disorder associated with increased risk of developing glaucoma

    Background

    Attention deficit hyperactivity disorder (ADHD) therapies including atomoxetine, methylphenidate, and amphetamines are some of the most...

    Rami Darwich, Mahyar Etminan, ... Brennan D. Eadie in Eye
    Article 06 May 2024

  18. Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder

    Atomoxetine (ATO) is a second line medication for attention-deficit hyperactivity disorder (ADHD). We proposed that part of the therapeutic profile...

    Frank Faltraco, Denise Palm, ... Johannes Thome in Journal of Neural Transmission
    Article Open access 17 July 2021

  20. Atomoxetine

    in Reactions Weekly
    Article 03 October 2020
Did you find what you were looking for? Share feedback.